Kidney transplants with progressing chronic diseases express high levels of acute kidney injury transcripts

American Journal of Transplantation

Volumn 13, Issue 3, 2013, Pages 634-644

  Famulski, K S ^a,b   Reeve, J ^a,b   De Freitas, D G ^b,c   Kreepala, C ^b   Chang, J ^b   Halloran, P F ^b,d  

^a Department of Laboratory Medicine and Pathology ^*  (United Kingdom)

^b UNIVERSITY OF ALBERTA   (Canada)

^c MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Fibrosis; gene expression; graft failure; inflammation; renal injury

Indexed keywords

A KINASE ANCHOR PROTEIN 12; ADAMTS1 PROTEIN; BETA3 INTEGRIN; BETA6 INTEGRIN; CADHERIN; CADHERIN 6; CATHEPSIN S; CD16 ANTIGEN; CHONDROITIN SULFATE PROTEOGLYCAN 2; CHROMOSOME 9 OPEN READING FRAME 71; EARLY GROWTH RESPONSE FACTOR 1; ECOTROPIC VIRAL INTEGRATION SITE 2A; LACTOFERRIN; MANGANESE SUPEROXIDE DISMUTASE; MEMBRANE PROTEIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; NICOTINAMIDE METHYLTRANSFERASE; NUCLEAR FACTOR OF KAPPA LIGHT POLYPEPTIDE GENE ENHANCER IN B CELL INHIBITOR, ZETA; OLFACTOMEDIN 4; ONCOSTATIN M RECEPTOR; PENTAXIN; PEPTIDASE INHIBITOR 15; PROTEIN MEGF 11; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE RECEPTOR C; PROTEOCHONDROITIN SULFATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; RETINOIC ACID RECEPTOR RESPONDER (TAZAROTENE INDUCED) 1; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG; VACUOLE MEMBRANE PROTEIN 1;

ACUTE KIDNEY FAILURE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; GENE EXPRESSION; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENT DISEASE;

ACUTE KIDNEY INJURY; BIOLOGICAL MARKERS; CHRONIC DISEASE; DISEASE PROGRESSION; FIBROSIS; GENE EXPRESSION PROFILING; GLOMERULONEPHRITIS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; INFLAMMATION; KIDNEY TRANSPLANTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84874417380     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12080     Document Type: Article

References (40)

1. Famulski KS, de Freitas DG, Kreepala C, et al. Molecular phenotypes of acute kidney injury in human kidney transplants. JASN 2012; 23: 948-958.
2. Venkatachalam MA, Griffin KA, Lan RP, Geng H, Saikumar P, Bidani AK,. Acute kidney injury: A springboard for progression in chronic kidney disease. Am J Physiol Renal Physiol 2010; 298: F1078-F1094.
3. Sharfuddin AA, Molitoris BA,. Pathophysiology of ischemic acute kidney injury. Nat Rev Nephrol 2011; 7: 189-200.
4. Devarajan P., Update on mechanisms of ischemic acute kidney injury. JASN 2006; 17: 1503-1520.
5. Chang HY, Sneddon JB, Alizadeh AA, Sood R, West RB, Montgomery K, et al. Gene expression signature of fibroblast serum response predicts human cancer progression: Similarities between tumors and wounds. Plos Biology 2004; 2: 206-214.
6. Riss J, Khanna C, Koo S, et al. Cancers as wounds that do not heal: Differences and similarities between renal regeneration/repair and renal cell carcinoma. Cancer Research 2006; 66: 7216-7224.
7. Bissell MJ, Radisky D,. Putting tumours in context. Nat Rev Cancer 2001; 1: 46-54.
8. Igarashi P, Shao X, McNally BT, Hiesberger T,. Roles of HNF-1beta in kidney development and congenital cystic diseases. Kidney Int 2005; 68: 1944-1947.
9. Wight TN, Merrilees MJ,. Proteoglycans in atherosclerosis and restenosis: Key roles for versican. Circ Res 2004; 94: 1158-1167.
10. Kinsella MG, Bressler SL, Wight TN,. The regulated synthesis of versican, decorin, and biglycan: Extracellular matrix proteoglycans that influence cellular phenotype. Crit Rev Eukaryot Gene Expr 2004; 14: 203-234.
11. Wu Y, Siadaty MS, Berens ME, Hampton GM, Theodorescu D,. Overlapping gene expression profiles of cell migration and tumor invasion in human bladder cancer identify metallothionein 1E and nicotinamide N-methyltransferase as novel regulators of cell migration. Oncogene 2008; 27: 6679-6689.
12. Siew ED, Ware LB, Ikizler TA,. Biological markers of acute kidney injury. J Am Soc Nephrol 2011; 22: 810-820.
13. Anderson S, Eldadah B, Halter JB, et al. Acute kidney injury in older adults. J Am Soc Nephrol 2011; 22: 28-38.
14. Ko GJ, Grigoryev DN, Linfert D, Jang HR, Watkins T, Cheadle C, et al. Transcriptional analysis of kidneys during repair from AKI reveals possible roles for NGAL and KIM-1 as biomarkers of AKI-to-CKD transition. Am J Physiol Renal Physiol 2010; 298: F1472-F1483.
15. Famulski KS, Broderick G, Hay K, et al. Transcriptome analysis reveals heterogeneity in the injury response of kidney transplants. Am J Transplant 2007; 7: 2483-2495.
16. Sellares J, de Freitas DG, Mengel M, et al. Inflammation lesions in kidney transplant biopsies: association with survival is due to the underlying diseases. Am J Transplant 2011; 11: 489-499.
17. Mengel M, Reeve J, Bunnag S, et al. Scoring total inflammation is superior to the current Banff inflammation score in predicting outcome and the degree of molecular disturbance in renal allografts. Am J Transplant 2009; 9: 1859-1867.
18. Famulski KS, Einecke G, Sis B, et al. Defining the canonical form of T-cell-mediated rejection in human kidney transplants. Am J Transplant 2010; 10: 810-820.
19. Einecke G, Reeve J, Sis B, et al. A molecular classifier for predicting future graft loss in late kidney transplant biopsies. J Clin Invest 2010; 120: 1862-1872.
20. Mueller TF, Einecke G, Reeve J, et al. Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets. Am J Transplant 2007; 7: 2712-2722.
21. Einecke G, Sis B, Reeve J, et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 2009; 9: 2520-2531.
22. Sellares J, De Freitas D, Mengel M, et al. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and non-adherence. Am J Transplant 2012; 12: 388-399.
23. de Freitas DG, Sellares J, Mengel M, et al. The nature of biopsies with "Borderline Rejection" and prospects for eliminating this category. Am J Transplant 2012; 12: 191-201.
24. Zeisberg M, Neilson EG,. Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol 2010; 21: 1819-1834.
25. Wight TN, Potter-Perigo S,. The extracellular matrix: An active or passive player in fibrosis? Am J Physiol Gastrointest Liver Physiol 2011; 301: G950-G955.
26. Eddy AA, Lopez-Guisa JM, Okamura DM, Yamaguchi I,. Investigating mechanisms of chronic kidney disease in mouse models. Pediatr Nephrol 2012; 27: 1233-1247.
27. Cosio FG, Grande JP, Wadei H, Larson TS, Griffin MD, Stegall MD,. Predicting subsequent decline in kidney allograft function from early surveillance biopsies. Am J Transplant 2005; 5: 2464-2472.
28. Park WD, Griffin MD, Cornell LD, Cosio FG, Stegall MD,. Fibrosis with inflammation at one year predicts transplant functional decline. J Am Soc Nephrol 2010; 21: 1987-1997.
29. Wen X, Murugan R, Peng Z, Kellum JA,. Pathophysiology of acute kidney injury: A new perspective. Contrib Nephrol 2010; 165: 39-45.
30. Akcay A, Nguyen Q, Edelstein CL,. Mediators of inflammation in acute kidney injury. Mediators Inflamm 2009; 2009: 137072.
31. Mannon RB, Matas AJ, Grande J, et al. Inflammation in areas of tubular atrophy in kidney allograft biopsies: A potent predictor of allograft failure. Am J Transplant 2010; 10: 2066-2073.
32. Anders HJ, Ryu M,. Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis. Kidney Int 2011; 80: 915-925.
33. Mengel M, Chang J, Kayser D, et al. The molecular phenotype of six-week protocol biopsies from human renal allografts: Reflections of prior injury but not future course. Am J Transplant 2011; 11: 708-718.
34. Einecke G, Kayser D, Vanslambrouck JM, et al. Loss of solute carriers in T cell mediated rejection in mouse and human kidneys: An active epithelial injury-repair response. Am J Transplant 2010; 10: 2241-2251.
35. Schnermann J, Levine DZ,. Paracrine factors in tubuloglomerular feedback: Adenosine, ATP, and nitric oxide. Annu Rev Physiol 2003; 65: 501-529.
36. Bonventre JV, Yang L,. Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest 2011; 121: 4210-4221.
37. Racusen LC, Regele H,. The pathology of chronic allograft dysfunction. Kidney Int Suppl 2010; 19: S27-S32.
38. Lee SB, Kalluri R,. Mechanistic connection between inflammation and fibrosis. Kidney Int Suppl 2010; 19: S22-S26.
39. Akalin E, O'Connell PJ,. Genomics of chronic allograft injury. Kidney Int Suppl 2010; 19: S33-S37.
40. Mannon RB,. Immune monitoring and biomarkers to predict chronic allograft dysfunction. Kidney Int Suppl 2010; 19: S59-S65.